Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry

The purpose of this clinical trial is to evaluate whether volatile organic compound (VOC) signatures detected in the breath of patients with cancer can serve as a potential screening tool for the early detection of cancer.

NCT Number	NCT07732686
Lead Sponsor	University of Oklahoma
Conditions	Pancreas Cancer, Hepatocellular Carcinoma, Lung Cancer, Ovarian Cancer, Breast Cancer, Head and Neck Cancer, Colon Cancer, Bladder Cancer +1 more
Enrollment	2,000 participants
Start Date	2026-10
Primary Completion	2027-10 (estimated)
Study Completion	2029-10 (estimated)
Updated on ClinicalTrials.gov	2026-07-29